Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03052686
Other study ID # CHRD0914
Secondary ID
Status Completed
Phase N/A
First received September 13, 2016
Last updated February 10, 2017
Start date January 2000
Est. completion date December 2013

Study information

Verified date February 2017
Source Centre Hospitalier René Dubos
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study has for objective to collect medical data from patients with uterine rupture at the childbirth.


Description:

This is a retrospective study, gathering data of five maternity in the department of Val d'Oise in France, during 13 years (between 01/01/2000 an 31/12/2013).

The incidence of uterine rupture increases with increasing cesarean rates. It occurs at a rate of 0.08% across all childbirths in France, and 0.5 to 1% of the childbirths on cicatricial uterus in France.

Although the risk factors are known, it is usually unexpected. This is a serious complication for the mother (mortality <1%, severe morbidity at 15% ) and for the child (mortality for 3 to 6 % for childbirth at term, neonatal asphyxia for 6 to 15%) that can occur during pregnancy or during labor.


Recruitment information / eligibility

Status Completed
Enrollment 110
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Childbirth with uterine rupture

Exclusion Criteria:

- Childbirth in a maternity which do not participate to the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Childbirth with uterine rupture
No intervention. Follow-up of women with rupture uterine at the childbirth.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier René Dubos

Outcome

Type Measure Description Time frame Safety issue
Primary Identify maternal and foetal risk factors associated to an uterine rupture ; by the report of events during pregnancy, pathology, lifestyle, Concomitant pathology... 1 day
Secondary Number of maternal and foetal adverse events associated to an uterine rupture at the childbirth. 1 day